Aldeyra Therapeutics, Inc. - Common Stock —— 现金流量表 (NASDAQ:ALDX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -37.49 M-42.56 M-56.64 M-30.33 M-43.21 M-33.35 M -25.99 M 投资活动产生的现金 29.02 M-7 806-29.95 M30 M-44.92 M47.74 M 40.45 M 融资活动产生的现金 41.9 M194.5 M1.22 M-1.27 M-171.42 K1.12 M 191.89 K 自由现金流 -37.49 M-42.56 M-56.64 M-30.33 M-43.21 M-33.35 M -25.99 M

新闻

Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.10%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC因干眼症竞争对手延迟而重申Bausch & Lomb股票评级

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

根据BTIG分析的今年顶级医疗保健股票

Top Healthcare Stocks for This Year According to BTIG